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A B S T R A C T
Crystal-storing histiocytosis (CSH) is a rare manifestation of monoclonal gammopathy in which histiocytes
containing monoclonal proteins in their cytoplasm are found in various organs of the body including the kidney.
Within the kidney, these monoclonal crystal-laden histiocytes have been described to occur in the interstitium
(most commonly) or in the glomerular mesangium. CSH within glomerular capillary loops has rarely been re-
ported. We describe three cases of CSH primarily affecting the glomerular capillaries and review the literature of
CSH in general. Twenty cases of CSH involving the kidney are present in the literature; three describe CSH in
glomeruli, only one of which showed histiocytes predominantly in glomerular capillary loops, while 15 had
predominantly or solely interstitial CSH. Most cases involve IgG kappa crystals with only one case involving
lambda light chain. Patients with CSH predominantly involving the glomerular capillaries showed a trend to-
ward lower serum creatinine and proteinuria at presentation, and several patients with CSH lacked a definitive
diagnosis of a monoclonal gammopathy at the time of diagnosis, emphasizing the role that kidney biopsy and
particularly electron microscopy play in diagnosis of this entity.
1. Introduction
Multiple myeloma (including monoclonal gammopathy of uncertain
significance [MGUS]) and various B-cell lymphoproliferative disorders
(mostly low-grade) often involve the kidney and result in a variety of
morphologic manifestations which can be subtyped based on light mi-
croscopic or ultrastructural features. These disorders usually show la-
boratory features of monoclonal gammopathy characterized by an un-
derlying plasma cell dyscrasia or a low-grade B-cell lymphoma, positive
monoclonal spike (M-spike) on immunoelectrophoresis (usually IgG or
IgM, rarely IgA), and elevated free kappa or lambda light chain [1].
Often, kidney biopsy for renal dysfunction and/or proteinuria is the
first indication of a monoclonal process. Morphologically, there is de-
position of monotypic kappa or lambda light chains or heavy chains (or
both) in the kidney, sometimes involving more than one compartment
(Fig. 1). Although many of the different morphologic entities are often
suspected by light microscopy, electron microscopy is the gold standard
by which these various monoclonal proteins are ultimately diagnosed
and classified.
Crystal-bearing or crystal-storing histiocytosis (CSH) is a rare mor-
phologic manifestation of monoclonal gammopathy in which
monoclonal crystals, usually belonging to kappa subtype and having
various geometric shapes, collect within histiocytes that, via systemic
circulation, end up in various organs [2-9]. In the kidney, such histio-
cytes have been historically described in the renal interstitium or oc-
casionally in the mesangium [5-8,10-23]. Crystal-storing histiocytes
involving the glomerular capillary loops have rarely been reported
[22].
We report several cases from our institution with striking gross,
light microscopic, and ultrastructural features, and extensively review
the existing literature on renal CSH, correlating histology with clinical
features.
2. Materials and methods
With IRB approval, computerized records of native kidney biopsies
received from 1/1/1994 to 12/31/2017 were searched using terms
monoclonal or gammopathy (650 cases out of 23,385), with subsequent
search of these results for crystal or histiocytosis. Four cases (< 0.02%)
diagnosed as crystal-storing histiocytosis were identified. One of these
was an initial biopsy on the patient presented here as Case 2 who was
subsequently re-biopsied. The demographic and clinical information
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provided at the time of biopsy and afterwards was recorded including
age at biopsy, gender, race, relevant past medical history, serum crea-
tinine, urinalysis and urine protein quantification, pertinent laboratory
tests and other pathology diagnoses, clinical course and follow up
(when documented).
2.1. Biopsies
Native kidney biopsies were processed for light microscopy, im-
munofluorescence, and electron microscopy as per standard protocol
for diagnostic evaluation. Biopsies and pathologic reports were re-
viewed by two nephropathologists (RKG and LJA).
Immunohistochemical staining on paraffin embedded tissue was per-
formed for CD68 (Ventana 790-2931), CD163 (Novacastra NCL-
CD163), CD138 (Ventana 760-4248), kappa light chain (Dako A0191),
lambda light chain (Dako A0193), S100 (Ventana 790-2914), and CD1a
(Novacastra IM1590) using standard immunohistochemical methods.
2.2. Immunoelectron microscopy
Immunogold electron microscopy was performed for kappa and
lambda light chains as follows. Biopsy tissue was fixed with 3% glu-
taraldehyde in 0.1 M phosphate buffer, pH 7.3 overnight at 4C. Tissue
was washed in the same buffer for 15min, 3 times, prior to secondary
fixation with 1% osmium tetroxide in 0.1 M phosphate buffer for 1 h at
room temperature. The tissues were dehydrated using a graded ethanol
series, transitioned through toluene, infiltrated and embedded with
Poly/Bed 812 epoxy resin, and polymerized overnight at 60C. Areas of
interest for immunoelectron microscopy (IEM) were selected from thick
sections (1 μm) stained with Toluidine blue. Thin sections (100 nm)
were cut with a diamond knife (DIATOME) and placed on 200 mesh
nickel grids for post-embed immunogold staining.
Prior to immunostaining, antibody binding sites were unmasked by
treating the sections with 4% sodium metaperiodate for 30min at room
temperature. After 3 rinses in deionized water for 1min each, non-
Fig. 1. The current spectrum of pathologic entities associated with monoclonal gammopathy in renal disease.
R.K. Gupta, et al. Annals of Diagnostic Pathology 43 (2019) 151403
2
specific binding sites were blocked by treating with 1% bovine serum
albumin (BSA) in phosphate buffered saline (PBS) for 10min at room
temperature.
Rabbit polyclonal antibodies (IgG) against human kappa (polyclonal
rabbit anti-human kappa light chain, Dako A0191) or lambda (poly-
clonal rabbit anti-human lambda light chain, Dako A0193) light chains
were used. The grids were floated on drops of primary antibody diluted
in 0.5% BSA/PBS and incubated overnight at 4C. Omission of primary
antibody served as method control. Parallel control grids were floated
on drops of 0.5% BSA/PBS only. The next day, after rinsing sections in
0.5% BSA/PBS for 5min, 3 times, the sections were incubated with
polyclonal goat affinity purified anti-rabbit IgG (H+ L) conjugated to
10 nm gold particles (Cytodiagnostics AC-10-01) for 1 h at room tem-
perature. The sections were washed in PBS for 5min, 3 times, stabilized
by post fixation in 3% glutaraldehyde in PBS for 3min, rinsed in
deionized water and air-dried on filter paper. Some grids were post-
stained with uranyl acetate and lead citrate to correlate gold labeling
with ultrastructure.
The grids were placed into a JEOL1400 Plus transmission electron
microscope (TEM) equipped with a lanthanum hexaboride cathode
operating at 80 kV accelerating voltage. The acquisition of electron
micrographs at various magnifications was performed using a
QUEMESA 11 megapixel bottom-mounted CCD TEM camera system
(Olympus Soft Imaging Solutions).
2.3. Statistical analysis




A 71-year old male presented with nephrotic-range proteinuria of
3.6 g/day and serum creatinine of 1.18mg/dL. He had a history of B-
cell lymphoproliferative disorder and Waldenstrom macroglobulinemia
for 17 years, for which he had received chemotherapy. He had disease
recurrence which required a splenectomy and additional cycles of
chemotherapy with a variety of regimens. A previous kidney biopsy
performed at an outside hospital 5 years prior to the current presenta-
tion had shown kappa-positive crystal-containing interstitial macro-
phages. Currently, his serum showed monoclonal IgM protein with
elevated free kappa light chain and a kappa/lambda ratio of 25. A
second kidney biopsy was performed.
The appearance of the fresh biopsy core using a dissecting micro-
scope was distinctly abnormal and showed hypertrophic solid-ap-
pearing glomeruli (Fig. 2a). On light microscopy, the biopsy contained
cortex and medulla with up to 24 glomeruli per section, of which 3–4
glomeruli were globally sclerosed. The remaining glomeruli showed a
striking appearance with dilated capillary loops filled with large his-
tiocyte-like cells containing eosinophilic cytoplasmic globules on H&E
(Fig. 2b) that were strongly fuchsinophilic on trichrome stain (Fig. 2c).
A few of these cells were also found scattered in the interstitium. The
tubules showed focal injury in the form of tubular cell vacuolization,
flattening of the epithelium and apical blebbing, along with a deep
eosinophilic appearance of the tubular epithelia. The interstitium
showed focal edema and patchy interstitial inflammatory infiltrates
composed of lymphocytes, plasma cells, and prominent eosinophils.
Arteries up to arcuate size were present, many of which showed mod-
erate to severe fibrointimal thickening. Immunohistochemical staining
for CD68 highlighted cells within the glomeruli and in the interstitium
(Fig. 2d). Immunohistochemistry for kappa and lambda light chains
showed the histiocytic cells to have restricted staining for kappa
(Fig. 2e & f). Direct immunofluorescence on frozen tissue revealed that
the histiocytes within the capillaries were positive for kappa light chain
(2+) and IgM (0–1+), and were negative for lambda, IgG, IgA, C3, and
C1q (Fig. 2g & h).
Toluidine blue stained thick sections highlighted the in-
tracytoplasmic globules within the histiocytes (Fig. 2i). Ultra-
structurally, the glomerular capillaries were occluded and distended by
large cells with electron-dense polygonal crystalline inclusions in their
cytoplasm (Fig. 2j & k). A few of these crystals were seen within the
cytoplasm of glomerular endothelial cells and others were seen appar-
ently representing circulating monoclonal protein free within the lu-
mina of peritubular capillaries (some being engulfed by macrophages;
Fig. 2l). Few proximal tubular cells also showed cytoplasmic crystalline
inclusions. On higher ultrastructural magnification the crystals revealed
a lattice substructure. The glomerular basement membranes were ir-
regularly thickened but did not show crystalline, granular, or powdery
electron-dense deposits. No electron-dense deposits were evident along
the tubular basement membranes. The podocytes showed segmental
effacement of up to 60% of the capillary surface. Immunoelectron mi-
croscopy using kappa and lambda gold particles confirmed kappa re-
striction of the crystals. Final diagnosis was rendered as crystal-storing
histiocytosis, kappa light chain-restricted, with dominant glomerular
involvement.
3.2. Case 2
A 67-year old male with a history of diabetes, hypertension, obesity,
and myelodysplastic syndrome was diagnosed several years prior to the
current presentation with ANCA-negative pauci-immune glomerulone-
phritis with arteritis and features of thrombotic microangiopathy. He
developed acute kidney injury five years later, with a serum creatinine
of 4.6mg/dL, which responded to IV fluids and was presumed sec-
ondary to use of non-steroidal anti-inflammatory drug (NSAID). Seven
months later he developed a rash, bilateral lower extremity edema,
anemia, low platelets, and increase in serum creatinine from 1.3mg/dL
to 1.8 mg/dL. Serum protein electrophoresis revealed an IgG kappa
monoclonal gammopathy and cryoglobulin screen was trace positive.
There were no radiologic or clinical signs of frank myeloma. A kidney
biopsy was performed at that time, and a second biopsy 2months later
for further worsening of renal function (serum creatinine 2.7mg/dL).
Most glomeruli had a membranoproliferative glomerulonephritis
(MPGN) appearance with histiocyte-like cells within capillary loops
containing small eosinophilic droplets or globules on H&E (Fig. 3a) and
double contours of the capillary walls on silver stain (Fig. 3b). There
was approximately 30–40% tubular atrophy and interstitial fibrosis,
with preserved tubules showing cytoplasmic vacuolization, apical
blebbing and thinning. On immunohistochemistry, the histiocytes were
positive for the monocyte markers CD68 and CD163 (Fig. 3c) and for
kappa, and were negative for CD138, S100, CD1a and lambda. Direct
immunofluorescence studies showed 3+ focal globular and segmental
staining in mesangium and capillaries for IgG, kappa, and C3. Toluidine
blue-stained thick sections highlighted the intra-histiocytic globules.
Ultrastructurally, many of the glomerular capillary loops showed
marginating cells with indented nuclei containing numerous cyto-
plasmic electron-dense round to oval crystalloid structures with smooth
outer contours (Fig. 3d). In a few glomeruli, these oval crystals were
seen within the cytoplasm of endothelial cells; rare foci also showed
more conventional granular subendothelial electron-dense deposits
(Fig. 3e). Immunoelectron microscopy showed particulate kappa gold
staining of the crystals, and no staining for lambda (Fig. 3f). Final di-
agnosis was MPGN due to IgG kappa crystal-storing histiocytosis.
3.3. Case 3
A 74-year old male developed acute renal failure, with an increase
in serum creatinine to 3.5 mg/dL from a baseline of 0.5mg/dL.
Proteinuria of 2 g per day was detected. Testing for ANCA, anti-GBM
antibody, Hepatitis B, and Hepatitis C was negative. A kappa
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Fig. 2. Biopsy images from Case 1: (a) gross picture of the frozen biopsy core under the dissecting microscope showing a large hypertrophic, solid-appearing
glomerulus (inset: gross picture of a kidney biopsy core of an unrelated case from our renal lab for comparison, showing normal-appearing glomeruli). (b)
Hematoxylin and eosin (H&E) image of a representative glomerulus showing enlarged, slightly lobulated glomerulus with capillary loops being almost completely
occluded with histiocyte-like cells having bright eosinophilic material in their cytoplasm (original magnification 400×); (c) Masson trichrome stain showing an
enlarged glomerulus with bright fuchsinophilic crystals within the histiocytes (original magnification 400×). (d) CD68 immunohistochemical stain highlighting the
histiocytes within the capillary loops (original magnification 400×). (e and f) Immunohistochemistry for kappa and lambda light chains, respectively, show strong
kappa staining of the crystals, and no staining for lambda within the glomerulus (original magnification 400×). (g and h) Direct immunofluorescence shows bright
staining for kappa and near-negative staining for lambda. (i) Thick section stained with toluidine blue shows prominent granular staining of the crystals within a
representative glomerulus (original magnification 400×). (j) Electron microscopic (EM) view of a glomerular tuft with most of capillary loops filled with hexagonal
crystals of varying sizes (magnification 10,000×). (k) EM image of the same glomerular tuft as in j at a higher power showing a crystal-laden macrophage
(magnification 50,000×). (l) EM image of a peritubular capillary lined by endothelial cells (E) with several free hexagonal crystals within the lumen (Lu), and a
monocyte-macrophage (M) at one corner within the lumen in the process of engulfing a crystal, a tubule (T) can be seen at one edge (magnification 50,000×), inset:
higher magnification of the macrophage engulfing the crystal, (magnification 80,000×).
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monoclonal spike was identified, and MGUS was suspected. A kidney
biopsy was performed.
Most of the glomeruli had an MPGN appearance with lobulation,
hypercellularity, focal cellular interpositioning and double contours,
and segmental intra-capillary histiocytes (Fig. 4a & b). As in the pre-
vious cases, the histiocytes showed strong fuchsinophilic staining of
their cytoplasm on trichrome stain (Fig. 4c). Several intratubular pro-
teinaceous casts were identified without definite fracturing or cellular
reaction. Intra-capillary CD68-positive histiocytes were seen having
globular cytoplasmic material which was positive only for kappa
(Fig. 4d–f). Many of the tubular casts also stained strongly for kappa. A
few interstitial CD68-positive histiocytes were also noted. Direct im-
munofluorescence showed globular endocapillary staining for IgG (3+)
and granular mesangial C3 (3+); casts stained more intensely for kappa
(3+) as compared to lambda (1+). Toluidine blue-stained sections
highlighted the histiocytic globules within the glomerular capillaries
(Fig. 4g). Ultrastructural examination revealed extensive glomerular
basement membrane and capillary wall duplication with cellular in-
terposition. Also seen was segmental occlusion of capillary lumina by
cells with eccentric curved nuclei filled with cytoplasmic globular or
ovoid electron-dense crystalloid bodies, many of which were also seen
within the cytoplasm of endothelial cells (Fig. 4h). Sparse subepithelial
and focal subendothelial granular electron-dense deposits were also
noted (Fig. 4i). Podocyte foot processes were diffusely effaced. Final
diagnosis was MPGN with IgG-kappa crystal-storing histiocytosis, as-
sociated with acute tubular injury. A comprehensive investigation re-
vealed that the patient had multiple myeloma.
3.4. Literature review and clinicopathologic correlation
In our review of the literature on CSH involving the kidney, 20 cases
were identified since 1978 (Table 1). Five of the cases [5-8,11] were
autopsies where kidney involvement by systemic CSH was suspected
antemortem but was only proven on postmortem histopathology. On
average, time to death from all causes after diagnosis was 4.5 years in
the nine cases in which the patient had died at the time of reporting
(range: 4 months to 25 years). There is a clear male predominance in
renal CSH (18 males, 4 females) with a mean age at diagnosis of
60 years (range: 41 to 74 years). All patients with predominant glo-
merular capillary involvement were male (with the possible exception
of Case #22, a female patient in whom the intraglomerular location was
not specified). Serum creatinine at presentation was 5.01 ± 4.43mg/
dL (average ± SD) in patients with interstitial involvement only and
2.38 ± 1.12mg/dL in those with predominantly glomerular involve-
ment by CSH (p= 0.22). Where 24-hour urine protein was reported,
the average proteinuria in patients with interstitial-only involvement
was 4.62 ± 7.68 g/day and 2.36 ± 1.27 g/day in those with pre-
dominantly glomerular involvement (p= 0.54). Seventeen of the pa-
tients had either overt myeloma or MGUS, with one case having addi-
tional type 1 cryoglobulinemia [22]. In addition, two cases (including
one of our own) had a history of lymphoplasmacytic lymphoma [11],
one had a history of low-grade B-cell lymphoproliferative disorder, type
unspecified [12], and one was diagnosed with diffuse large B-cell
lymphoma a few months after the kidney biopsy [20]. Regarding light
chain type, kappa was overwhelmingly the predominant light chain,
with only one case showing IgM lambda protein [12]. Overall, IgG
kappa was found to be the most common monoclonal protein (11
cases), along with 2 cases of IgM kappa, 2 cases of IgA kappa, one case
of IgD kappa, and 3 cases having only monoclonal kappa light chain. As
the table shows, the crystal-laden histiocytes were found most com-
monly in the interstitium; only a single journal image [21] and a case
report [22] describe these histiocytes within the glomerular tuft, with
only the published image mentioning it as occurring within the glo-
merular capillary loops (the first of two biopsies from Case 2). In three
cases, CSH was reported as the sole renal pathology finding [11,12,18],
while in the majority of cases (78.3%) at least one other manifestation
of a monoclonal process co-existed with renal CSH. Twelve of these
included LCPT, seven showed crystalloid glomerulopathy, and five had
associated LCCN. Interestingly, two cases described extra-renal amyloid
deposition as a co-existing process. Overall, nine cases (39.1%) showed
Fig. 3. Biopsy images from Case 2: (a) H&E image of a representative slightly enlarged glomerulus having a membranoproliferative glomerulonephritis (MPGN)-like
appearance and showing partial occlusion of many capillary loops with histiocyte-like cells having an eccentric nucleus and bright eosinophilic granular cytoplasm
(original magnification 400×). (b) Glomerulus showing distinct double contours (black arrowhead) of capillary walls (original magnification 400×). (c) CD163
immunostain highlighting the histiocytes within the capillary loops (original magnification 400×). (d) EM shows spherical electron-dense crystals within the
cytoplasm of a histiocyte having an eccentric nucleus (magnification 50,000×). (e) EM of a glomerulus with granular mesangial and subendothelial electron-dense
deposits (magnification 40,000×). (f) Immunoelectron microscopy image showing a glomerulus with kappa gold particles labeling the spherical crystals (magni-
fication 50,000×). Inset: EM image showing absence of staining of the same crystals by lambda gold particles (magnification 50,000×).
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renal involvement by more than one additional manifestation, invol-
ving glomeruli, tubules, and interstitium. Involvement of renal vessels
has not been described.
4. Discussion
Plasma cell dyscrasias and chronic B-cell lymphoproliferative dis-
orders often result in monoclonal protein deposition (either kappa or
lambda light chains or heavy chains) in different compartments of the
kidney as various light microscopic and ultrastructural entities falling
under the umbrella of monoclonal gammopathy-associated renal pa-
thology. While cast nephropathy is still the most common pathology
occurring in the kidney in such circumstances, monoclonal deposits
with other morphologic forms have also been described and are often
best seen ultrastructurally. These deposits seen by electron microscopy
(EM), usually either have a substructure (fibrils, crystals, or micro-
tubules) or are in the form of amorphous powdery deposits along glo-
merular or tubular basement membranes. Monoclonal crystals can take
either of the following forms – (a) crystals within one or more cell types
of the kidney which may be glomerular (mesangial cell and visceral
epithelial cell) and/or extra-glomerular (usually proximal tubular epi-
thelial cell), (b) extracellular crystals within glomerular capillary loops
or within interstitial vessel lumina, and (c) infiltration of crystal-
bearing histiocytes (Fig. 5).
Crystal-storing histiocytosis (CSH) is a rare pathologic variant of
monoclonal protein-associated disease in which histiocytes containing
monoclonal crystals in their cytoplasm are found in single or multiple
organs of the body such as bone marrow, lungs, liver, stomach, spleen,
kidney, skin, and cornea. These histiocytes have also been referred to as
pseudo-pseudo-Gaucher cells (PPGC) in past literature to distinguish
Fig. 4. Biopsy images from Case 3: (a) H&E image of a representative glomerulus having an MPGN appearance and scattered histiocyte-like cells with eosinophilic
cytoplasm within many of its capillary loops (original magnification 400×). (b) PAS stain showing the histiocytes with pale foamy cytoplasm occluding the capillary
loops within a glomerulus (original magnification 400×). (c) A Masson trichrome stain showing a similar glomerulus with histiocytes with bright fuchsinophilic
material within the capillary loops (original magnification 400×). (d) CD68 immunostain highlighting the histiocytes in the glomerulus (original magnification
400×). (e and f) Kappa (e) and lambda (f) immunostains respectively show positive and negative staining of the glomerular crystals (original magnification 200×).
(g) Thick section stained with toluidine blue showing segmental granular staining of the crystals within few of the capillary loops (original magnification 400×). (h)
EM view of a macrophage cell almost occluding a capillary loop with several oval electron-dense crystals within its cytoplasm (magnification 50,000×). (i) An
endothelial cell lining a capillary loop filled with the same oval electron-dense crystals (magnification 50,000×).
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them from the true Gaucher cells seen in Gaucher's disease and pseudo-
Gaucher cells sometimes seen in the bone marrow in chronic myeloid
leukemia [2,5,24].
It should be noted that the term CSH with regards to kidney should
be used only when crystals are found within histiocytes and not when in
situ crystals are found within endogenous glomerular cells [25,26] or
free within renal microvascular lumina [27] as outlined in Table 1 and
emphasized by Hoelbeek et al. [22]. At the same time, it should be
noted that in the kidney CSH is rarely a stand-alone pathology, and is in
fact, often found co-existing with other morphologic forms of mono-
clonal renal disease (both crystal and non-crystal forms) – including
light chain proximal tubulopathy or LCPT - usually crystalline subtype,
crystalloid glomerulopathy or nephropathy, and cast nephropathy.
The crystals as described in the literature are commonly rhomboidal
or needle-shaped and vary from being rarely electron-lucent to more
commonly electron-dense structures, and often displaying a lattice-like
substructure or periodicity [5,6,10,11]. While the crystals in our first
case had a definite lattice configuration on EM, the crystals or crys-
talloids in cases 2 and 3 were quite unique in being round to oval
structures without substructure or periodicity on EM. When crystals
have such unusual configuration, immunoelectron microscopy can be
very helpful to confirm their monoclonal nature [28]. Many of the EM
descriptions in earlier literature also describe these crystals surrounded
by a unit membrane, although such a description is lacking in later
literature [7,10,11].
The pathogenesis of CSH per se and the pathogenesis behind the
overwhelming involvement of kappa light chain in crystal formation as
compared to lambda, are closely linked albeit separate processes.
Regarding CSH, it has been hypothesized that either the crystal for-
mation occurs mainly within the monoclonal marrow plasma cells and
the histiocytes are bystanders ingesting either free crystals or crystal-
laden dying plasma cells, subsequent to which these crystals are pooled
within the histiocytes to form larger crystals, or alternatively, the ab-
normal kappa light chains are released by the plasma cells into the
peripheral blood, ingested by macrophages into their phagosomes
through endocytosis, then incorporated within their secondary lyso-
somes where they undergo further degradation and polymerization to
form crystalline inclusions [6,7,20,29]. However, many believe that
simple light chain overproduction is not sufficient for CSH and also does
not fully explain why kappa light chain is the culprit in most cases.
Unusual hydrophobic residues at the variable (V) domain of the kappa
light chain at position 30 or unusual amino acid substitutions in the V
region are believed to render the kappa crystals resistant to lysosomal
degradation within the histiocytes or elsewhere [5,12,17,30,31].
In conclusion, we present three unique cases where the glomerular
capillary loops, rather than the more commonly affected interstitium,
were predominantly involved by collections of kappa-predominant
crystal-storing histiocytes. As review of past literature and our current
cases demonstrates, the clinical presentation of renal CSH can be varied
and complex. Patients with monoclonal disease may present with only
mild proteinuria along with slight renal dysfunction as evidenced by a
minimal rise in serum creatinine, though the majority of cases show
involvement of multiple compartments of the kidney. In these cases,
identification of crystal-storing histiocytes in the kidney may serve as
the only diagnostic clue to an underlying monoclonal disease, either a
plasma cell dyscrasia (MGUS or frank myeloma) or a low-grade or very
rarely, a high-grade B-cell lymphoma, with or without bone marrow
involvement. Alternatively, there may be extreme accumulation of
crystal-storing histiocytes involving multiple organs, in which the CSH
process may exceed the actual myeloma disease burden, resulting in
considerable morbidity and even mortality [4,5,12]. Interestingly,
while not statistically significant, there appears to be a trend toward
Fig. 5. Flowchart depicting the spectrum of kidney involvement with monoclonal crystals.
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greater renal dysfunction and higher proteinuria in patients with more
interstitial burden of crystal-laden histiocytes than with predominantly
glomerular involvement. Thus, in all monoclonal cases with renal
symptoms, a kidney biopsy with reflex EM is very important for both
diagnosis and prognosis of the patient.
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